Source: International Congress 2016 – Clinical update on bronchiectasis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Miguel Ángel Martínez García (Valencia, Spain), Miguel Ángel Martínez García, R.A. Athanazio, G. Gramblicka, M. Corso, F.L. Cavalcanti-Lundgren, M.R. Fernandes de Figuereido, F. Arancibia. International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis. Eur Respir J 2016; 48: Suppl. 60, 275

Member's Comments

No comment yet.

Related content which might interest you: Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Exercise capacity is related with FACED score for disease severity in non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Exacerbations in non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Etiology and evolution of bronchiectasis in men Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies? Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Health-related quality of life in idiopathic pulmonary fibrosis (IPF): First results based on the European IPF registry Source: International Congress 2014 – ILDs 1 Year: 2014 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 The weight of radiological severity in patients with non-CF bronchiectasis Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Tuberculosis in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Characteristic of a subgroup of non cystic fibrosis bronchiectasis with concomitant asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 A meta-analysis of health related quality of life (HRQOL) in non-cystic fibrosis bronchiectasis (NCFB): Association with clinical outcomes Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014